HOME /

News & Events

CannMed 2020 Conference September 20-22

September 20, 2020

CannMed showcases the greatest minds in cannabis science, medicine, cultivation, and safety. CannMed was founded by Medicinal Genomics to promote understanding of cannabis' complex science and its medical benefits for patients in need. Since its founding in 2016, cannabis industry leaders have chosen CannMed to announce their latest findings and present breakthrough technologies to the world.

Research projects were awarded funding by the Israel Science Foundation and Scopus BioPharma Israel Ltd.

August 12, 2018

 

Congratulations to our researchers who were awarded funding by the Israel Science Foundation:

  1. Joseph Tam - Deciphering the Crosstalk between CB1 and GLUT2 in the Development of Diabetic Nephropathy
  2. Dmitry Tsvelikhovsky - Stretching the Model of TRPV1 Activation

 

Congratulations to our researchers who were awarded funding by Scopus BioPharma Israel Ltd:

2 research projects were awarded funding by Integra Holdings

April 22, 2018

 

Congratulations to our researchers:

  1. Avi Priel & Masha Niv - Towards novel migraine drugs: activation of the pain receptor TRPA1 by cannabinoids
  2. Joseph Tam, Amiram Goldblum & Yuval Tabach - Discovery and Experimental Confirmation of Novel (Dual-Targeted) Peripherally Restricted CB1 Receptor Antagonists

 

2 research projects were awarded funding by CIITECH

November 5, 2017

 

Congratulations to our researchers:

  1. Prof. Raphael Mechoulam & Prof. Francesca Levi-Schaffer - The therapeutic benefit of cannabis for the treatment of asthma
  2. Joseph Tam - Testing the therapeutic effect of phytocannabinoids for nonalcoholic fatty liver disease

 

The 2017 Israel Medical Convention

August 8, 2017

 

The 2017 Israel Medical Convention will focus on medical cannabis. Prof. Raphael Mechoulam, Head of the MCCR Academic Committee, will give a lecture on the past and future of cannabis.

Admission is free - register at www.hadassah.org.il.

 

3 research projects were awarded the 1st cycle of funding by the Center:

February 6, 2017

 

Congratulations to our winning researchers:

  1. Dr. Ofra Benny - Studying the anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists
  1. Prof. Elyad Davidson - Effect of a cannabis extract on acute radicular pain and on analgesics. Requirement: a double-blinded, randomized, 24 hours follow-up study
  1. Prof. Rami Yaka & Prof. Oren Ostresetzer - The Effects of CBD on Traumatic Brain Injury